VIM and central nervous system cancer: When GII/GIII-IDHmut gliomas were compared to GIV gliomas, significant differences of DNA methylation in the promoters of S100A2, RAB36, RIN1, UPP1, and VIM were found (Additional file 2: Fig. S5C).